The Role of Exposure History on HIV Acquisition: Insights from Repeated Low-dose Challenge Studies

PLoS Computational Biology

Volumn 8, Issue 11, 2012, Pages

  Regoes, Roland R ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; IMMUNIZATION; STOCHASTIC MODELS; STOCHASTIC SYSTEMS; VACCINES; VIRUSES;

EXPOSURE HISTORY; GENETIC DIFFERENCES; LOW DOSE; MODEL I; POWER ANALYSIS; PREVENTIVE TREATMENTS; RESEARCH GROUPS; STATISTICAL POWER; STOCHASTIC-MODELING; SUSCEPTIBILITY DIFFERENCES;

ANIMALS;

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; TRIPARTITE MOTIF PROTEIN 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL MONKEY; GENETIC DIFFERENCE; GENETIC SUSCEPTIBILITY; GEOMETRY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INFECTION PREVENTION; INFECTION SENSITIVITY; NONHUMAN; RHESUS MONKEY; STOCHASTIC MODEL; VALIDATION PROCESS; VIRUS RESISTANCE;

EID: 84870717488     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1002767     Document Type: Article

References (27)

1. Ma ZM, Abel K, Rourke T, Wang Y, Miller CJ, (2004) A period of transient viremia and occult infection precedes persistent viremia and antiviral immune responses during multiple low-dose intravaginal simian immunodeficiency virus inoculations. J Virol 78: 14048-52.
2. McDermott AB, Mitchen J, Piaskowski S, De Souza I, Yant LJ, et al. (2004) Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immuno-logical kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates. J Virol 78: 3140-4.
3. Otten RA, Adams DR, Kim CN, Jackson E, Pullium JK, et al. (2005) Multiple vaginal expo-sures to low doses of R5 simian-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates. J Infect Dis 191: 164-73.
4. Van Rompay KK, Abel K, Lawson JR, Singh RP, Schmidt KA, et al. (2005) Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV. J Acquir Immune Defic Syndr 38: 124-34.
5. Ellenberger D, Otten RA, Li B, Aidoo M, Rodriguez IV, et al. (2006) HIV-1 DNA/MVA vaccina-tion reduces the per exposure probability of infection during repeated mucosal SHIV challenges. Virology 352: 216-225.
6. Wilson NA, Reed J, Napoe GS, Piaskowski S, Szymanski A, et al. (2006) Vaccine-induced cellu-lar immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239. J Virol 80: 5875-85.
7. Letvin NL, Rao SS, Dang V, Buzby AP, Korioth-Schmitz B, et al. (2007) No evidence for consistent virus-specific immunity in simian immunodeficiency virus-exposed, uninfected rhesus monkeys. J Virol 81: 12368-12374.
8. Garcia-Lerma JG, Otten RA, Qari SH, Jackson E, Cong ME, et al. (2008) Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir. PLoS Med 5: e28.
9. Hansen SG, Vieville C, Whizin N, Coyne-Johnson L, Siess DC, et al. (2009) Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat Med 15: 293-9.
10. Wilson NA, Keele BF, Reed JS, Piaskowski SM, MacNair CE, et al. (2009) Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge. J Virol 83: 6508-21.
11. Hessell AJ, Poignard P, Hunter M, Hangartner L, Tehrani DM, et al. (2009) Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques. Nat Med 15: 951-4.
12. Reynolds MR, Weiler AM, Piaskowski SM, Kolar HL, Hessell AJ, et al. (2010) Macaques vaccinated with simian immunodeficiency virus SIVmac239Delta nef delay acquisition and control replication after repeated low-dose heterologous SIV challenge. J Virol 84: 9190-9.
13. Letvin NL, Rao SS, Montefiori DC, Seaman MS, Sun Y, et al. (2011) Immune and Genetic Cor-relates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys. Sci Transl Med 3: 81ra36.
14. Regoes RR, Longini IM, Feinberg MB, Staprans SI, (2005) Preclinical assessment of HIV vaccines and microbicides by repeated low-dose virus challenges. PLoS Med 2: e249.
15. Hansen SG, Ford JC, Lewis MS, Ventura AB, Hughes CM, et al. (2011) Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 473: 523-7.
16. Vaupel JW, Yashin AI, (1985) Heterogeneity's ruses: some surprising effects of selection on popu-lation dynamics. Am Stat 39: 176-85.
17. Hudgens MG, Gilbert PB, Mascola JR, Wu CD, Barouch DH, et al. (2009) Power to detect the effects of HIV vaccination in repeated low-dose challenge experiments. J Infect Dis 200: 609-13.
18. Hudgens MG, Gilbert PB, (2009) Assessing vaccine effects in repeated low-dose challenge experi-ments. Biometrics 65: 1223-32.
19. Halloran ME, Longini IM Jr, Struchiner CJ, (1996) Estimability and interpretation of vaccine efficacy using frailty mixing models. Am J Epidemiol 144: 83-97.
20. Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, et al. (2001) Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357: 1149-1153.
21. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, et al. (2005) Rates of HIV-1 transmis-sion per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 191: 1403-9.
22. Kaul R, Rowland-Jones SL, Kimani J, Fowke K, Dong T, et al. (2001) New insights into HIV-1 spe-cific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers. Immunol Lett 79: 3-13.
23. Clerici M, Clark EA, Polacino P, Axberg I, Kuller L, et al. (1994) T-cell proliferation to subinfec-tious SIV correlates with lack of infection after challenge of macaques. AIDS 8: 1391-5.
24. Dittmer U, Stahl-Hennig C, Coulibaly C, Nisslein T, Lke W, et al. (1995) Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge. J Gen Virol 76 (Pt 6) (): 1307-15.
25. Harouse JM, Gettie A, Eshetu T, Tan RCH, Bohm R, et al. (2001) Mucosal transmission and induction of simian AIDS by CCR5- specific simian/human immunodeficiency virus SHIVSF162P3. J Virol 75: 1990-1995.
26. Severini TA (2000) Likelihood Methods in Statistics. Oxford University Press, 123-129 pp.
27. R Development Core Team (2010) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org. ISBN 3-900051-07-0.